Merck falls; Visa down following quarterly results
By Carla Mozee, MarketWatch
Last Update: 7:36 PM ET Apr 28, 2008
SAN FRANCISCO (MarketWatch) — Merck & Co. shares fell more than 5% late Monday
after the U.S. Food and Drug Administration rejected the company’s request for
approval of a potentially lucrative drug to treat cholesterol, and investors sold
off shares of Visa [...]